上海918博天堂生物药业股份有限公司-A Randomized，Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 with Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

Research and Development

2021-06-17 1140

A Randomized，Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 with Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

Original Research Article：

Frontiers in Pharmacology

http://doi: 10.3389/fphar.2021.694375

918博天堂(中华区)官方网站